a4B7 integrin thioether peptide antagonists

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9714270
SERIAL NO

14714198

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to thioether monomer and dimer peptide molecules which inhibit binding of α4β7 to the mucosal addressing cell adhesion molecule (MAdCAM) in vivo.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PROTAGONIST THERAPEUTICS INC7707 GATEWAY BOULEVARD NEWARK CA 94560-1160

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bhandari, Ashok Pleasanton, US 67 947
Frederick, Brian Troy Ben Lomond, US 39 574
Mattheakis, Larry C Cupertino, US 39 878
Patel, Dinesh V Fremont, US 71 1372
Zemede, Genet San Jose, US 26 448

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jan 25, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jan 25, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00